Ann: Final Nyrada Phase I Clinical Trial Cohort to Commence, page-2

  1. 1,362 Posts.
    lightbulb Created with Sketch. 175
    Primary objective now completed with perfection. Congrates holders

    3 hour infusion produced 42 percent cardiovascular protection and that’s cleared for dosing. 6 hour infusion coming up shortly produced upto 88 percent cardiovascular protection.


    Last edited by Bendunstan: 14/07/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.0¢
Change
0.030(10.7%)
Mkt cap ! $65.38M
Open High Low Value Volume
28.5¢ 32.0¢ 28.5¢ $167.8K 559.6K

Buyers (Bids)

No. Vol. Price($)
2 13044 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 6562 2
View Market Depth
Last trade - 11.26am 21/07/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.